Brief: IDEAYA Biosciences Announces Clinical Collaboration With Roche In Mtap-Deleted Ras-Mutant Pancreatic Cancer
03/06/2026 11:25
BRIEF-IDEAYA Biosciences Announces Clinical Collaboration With Roche In Mtap-Deleted Ras-Mutant Pancreatic Cancer June 3 (Reuters) - IDEAYA Biosciences Inc IDYA.O:
IDEAYA BIOSCIENCES ANNOUNCES CLINICAL COLLABORATION WITH ROCHE IN MTAP-DELETED RAS-MUTANT PANCREATIC CANCER
IDEAYA BIOSCIENCES - TO SPONSOR CLINICAL TRIAL WITH JOINT GOVERNANCE WITH ROCHE
IDEAYA BIOSCIENCES - TO INITIATE PHASE 1 COMBINATION COHORTS IN PDAC AND NSCLC
IDEAYA BIOSCIENCES - CO AND ROCHE RETAIN ALL COMMERCIAL RIGHTS TO THEIR RESPECTIVE COMPOUNDS
Source text: ID:nPn5g2pwda
Further company coverage: IDYA.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on IDEAYA Biosciences
See all newsBrief: Ideaya Biosciences And Servier Announce Data From Three Clinical Trials At Esmo 2026 Supporting The Potential Of Darovasertib To Become A Foundational New Therapy For Patients Across The Treatment Journey Of Uveal Melanoma
Brief: Ideaya Biosciences Announces The Promotion Of Dr. Michael White To President, Research And Development
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj